tetano
Editor, Senior Moderator
Am J Otolaryngol
. 2021 Sep 16;43(1):103239.
doi: 10.1016/j.amjoto.2021.103239. Online ahead of print.
Predictors of smell recovery in a nationwide prospective cohort of patients with COVID-19
Daniel H Coelho[SUP] 1 [/SUP], Evan R Reiter[SUP] 2 [/SUP], Serenity G Budd[SUP] 3 [/SUP], Yongyun Shin[SUP] 3 [/SUP], Zachary A Kons[SUP] 4 [/SUP], Richard M Costanzo[SUP] 2 [/SUP]
Affiliations
Abstract
Objective: To determine which factors (demographic, symptoms, comorbidities, and treatments) are associated with recovery of smell in patients with COVID-19 associated olfactory loss.
Study design: Prospective, longitudinal questionnaires.
Setting: National survey.
Methods: A longitudinal web-based nationwide survey of adults with COVID-19 associated smell and taste loss was launched April 10, 2020. After completing an initial entry survey, participants received detailed follow-up questionnaires 14 days, and 1, 3 and 6 months later.
Results: As of June 25, 2021, 798 participants met study inclusion criteria and completed 6-month questionnaires. Of demographic characteristics only age <40 years was positively associated with smell recovery (p < .003). Of symptoms, difficulty breathing was negatively associated with smell recovery (p < .004), and nasal congestion positively associated with smell recovery (p < .03). Of pre-existing comorbidities only previous head injury (p < .017) was negatively associated with smell recovery. None of the queried medications used to treat COVID were associated with better rates of smell recovery.
Conclusions: Age <40 and presence of nasal congestion at time of COVID-19 infection were predictive of improved rates of smell recovery, while difficulty breathing at time of COVID-19 infection, and prior head trauma predicted worsened rates of recovery. Further study will be required to identify potential mechanisms for the other observed associations. Such information can be used by clinicians to counsel patients suffering COVID-19 associated smell loss as to prognosis for recovery.
Keywords: COVID-19; Coronavirus; Epidemiology; Recovery; Risk factors; Smell; Taste.
. 2021 Sep 16;43(1):103239.
doi: 10.1016/j.amjoto.2021.103239. Online ahead of print.
Predictors of smell recovery in a nationwide prospective cohort of patients with COVID-19
Daniel H Coelho[SUP] 1 [/SUP], Evan R Reiter[SUP] 2 [/SUP], Serenity G Budd[SUP] 3 [/SUP], Yongyun Shin[SUP] 3 [/SUP], Zachary A Kons[SUP] 4 [/SUP], Richard M Costanzo[SUP] 2 [/SUP]
Affiliations
- PMID: 34547716
- DOI: 10.1016/j.amjoto.2021.103239
Abstract
Objective: To determine which factors (demographic, symptoms, comorbidities, and treatments) are associated with recovery of smell in patients with COVID-19 associated olfactory loss.
Study design: Prospective, longitudinal questionnaires.
Setting: National survey.
Methods: A longitudinal web-based nationwide survey of adults with COVID-19 associated smell and taste loss was launched April 10, 2020. After completing an initial entry survey, participants received detailed follow-up questionnaires 14 days, and 1, 3 and 6 months later.
Results: As of June 25, 2021, 798 participants met study inclusion criteria and completed 6-month questionnaires. Of demographic characteristics only age <40 years was positively associated with smell recovery (p < .003). Of symptoms, difficulty breathing was negatively associated with smell recovery (p < .004), and nasal congestion positively associated with smell recovery (p < .03). Of pre-existing comorbidities only previous head injury (p < .017) was negatively associated with smell recovery. None of the queried medications used to treat COVID were associated with better rates of smell recovery.
Conclusions: Age <40 and presence of nasal congestion at time of COVID-19 infection were predictive of improved rates of smell recovery, while difficulty breathing at time of COVID-19 infection, and prior head trauma predicted worsened rates of recovery. Further study will be required to identify potential mechanisms for the other observed associations. Such information can be used by clinicians to counsel patients suffering COVID-19 associated smell loss as to prognosis for recovery.
Keywords: COVID-19; Coronavirus; Epidemiology; Recovery; Risk factors; Smell; Taste.